409 West Pender Street
Suite 1500
Vancouver, BC V6E 2M6
Canada
778 522 2261
http://www.mym.ca
Sector(s):Â Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:Â
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Mark G. Forster | Chief Financial Officer | N/A | N/A | N/A |
Mr. Robin Linden | Exec. VP, Chief Marketing Officer & Director | N/A | N/A | N/A |
Mr. Michael Wiener | CEO & Director | N/A | N/A | N/A |
Mr. James Andrews | VP of Operations | N/A | N/A | N/A |
Mr. Billy Casselman | VP of Commercial Sales & Investor Relations | N/A | N/A | N/A |
Ms. Fiona Orr | Legal Counsel | N/A | N/A | N/A |
Matthew Simms | Head of Sales | N/A | N/A | N/A |
Mr. Laird Choi | Exec. VP of Corp. Services | N/A | N/A | N/A |
Sheryl Dhillon | Corp. Sec. | N/A | N/A | N/A |
MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
MYM Nutraceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.